INATHERYS
Inatherys is a biotechnology company developping monoclonal antibodies for the treatment of cancers and inflammatory diseases.
INATHERYS
Industry:
Biotechnology Health Care Medical
Address:
Fontaine, Bourgogne, France
Country:
France
Website Url:
http://www.inatherys.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics Apple Mobile Web Clips Icon Google Tag Manager Content Delivery Network Google Universal Analytics Apache
Similar Organizations
IcanoMAB
IcanoMAB is a biotech company focusing on pre-clinical and clinical development for the treatment of cancer and other related diseases.
Nordic Rebalance
Nordic Rebalance primarily focussed on developing a dietary treatment for irritable bowel syndrome and inflammatory bowel diseases.
Syntopix Group
Syntopix Group is a drug development company focused on prescription and over-the counter products for the treatment of common inflammatory.
Official Site Inspections
http://www.inatherys.com
- Host name: 217-160-0-203.elastic-ssl.ui-r.com
- IP address: 217.160.0.203
- Location: Germany
- Latitude: 51.2993
- Longitude: 9.491
- Timezone: Europe/Berlin
More informations about "Inatherys"
Inatherys, biotechnology company : monoclonal antibodies
Founded in 2009, Inatherys is a biotechnology company spin-off from INSERM (Institut National de la Santé et de la Recherche Médicale). ... Before that, she held different positions in the …See details»
Inatherys - Crunchbase Company Profile & Funding
Inatherys is a biotechnology company developping monoclonal antibodies for the treatment of cancers and inflammatory diseases. ... Chrome Extension. Solutions. Products. Resources. …See details»
INATHERYS - LinkedIn
INATHERYS is a clinical-stage biotech advancing precision drug delivery, turning cancer’s energy dependency against itself. Our lead asset, an ADC targeting CD71, is designed to address …See details»
Inatherys - Products, Competitors, Financials, Employees, …
Inatherys is a biotechnology company focused on the development of monoclonal antibodies for therapeutic applications in the healthcare sector. The company's main offerings include …See details»
Inatherys Company Profile - Office Locations, Competitors ... - Craft
Inatherys is a biotechnology company developing monoclonal antibodies. It is engaged in the design and development of molecules providing solutions for the treatment of advanced …See details»
Inatherys SAS - Drug pipelines, Patents, Clinical trials - Synapse
Inatherys, a biotechnology company from academic research. Founded in 2009, Inatherys is a biotechnology company spin-off from INSERM. ... The statistics for drugs in the Pipeline is the …See details»
Inetherys - VentureRadar
Inatherys is a biotechnology company developing monoclonal antibodies for therapies for cancers and severe inflammatory diseases resistant to conventional treatment. INA03 and new …See details»
Présentation de la société INATHERYS - Societe.com
INATHERYS, société par actions simplifiée, au capital social de 91700,40 EURO, dont le siège social est situé au 4 RUE PIERRE FONTAINE, 91000 EVRY-COURCOURONNES, …See details»
Inatherys - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Inatherys is a biotechnology company developping monoclonal antibodies for the treatment of cancers and inflammatory diseases. Search Crunchbase. Start Free Trial . Chrome Extension. …See details»
Inatherys - Crunchbase
Inatherys is a biotechnology company developping monoclonal antibodies for the treatment of cancers and inflammatory diseases. Search Crunchbase. Start Free Trial . Chrome Extension. …See details»
INATHERYS Company Profile | PARIS, ILE DE FRANCE, France
Find company research, competitor information, contact details & financial data for INATHERYS of PARIS, ILE DE FRANCE. Get the latest business insights from Dun & Bradstreet. D&B …See details»
INATHERYS Company Profile | EVRY COURCOURONNES, ILE DE …
INATHERYS Company Profile | EVRY COURCOURONNES, ILE DE FRANCE, France | Competitors, Financials & Contacts - Dun & Bradstreet Find company research, competitor …See details»
Working at Inatherys - Glassdoor
Glassdoor gives you an inside look at what it's like to work at Inatherys, including salaries, reviews, office photos, and more. This is the Inatherys company profile. All content is posted …See details»
with an ADC targeting cancer cells
Developed by the French biotech Inatherys, a tech transfer from academic research, and in close collaboration with the Paoli-Calmettes Institute (IPC), the new treatment INA03 is now in a …See details»
Delving into the Latest Updates on Inatherys SAS with Synapse
了解Inatherys SAS (Inatherys SAS)公司的药物管线，治疗领域，技术平台，以及它的1项临床试，疾病领域:肿瘤，血液及淋巴系统疾病，免疫系统疾病，技术平台:单克隆抗体，ADC，药 …See details»
Inatherys SAS - Drug pipelines, Patents, Clinical trials - Synapse
Explore Inatherys SAS with its drug pipeline, therapeutic area, technology platform, 1 clinical trial, Disease Domain:Neoplasms, Hemic and Lymphatic Diseases, Immune System Diseases, …See details»
INA-01 - Drug Targets, Indications, Patents - Synapse
Nov 21, 2024 Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.See details»
Research programme: anti-CD89 monoclonal antibody - Inatherys
Inatherys is developing an anti-CD89 monoclonal antibody for the treatment of inflammation, including severe inflammatory diseases, such as asthma, arthritis Research programme: anti …See details»
What is Inatherys? Company Culture, Mission, Values
See what employees say it's like to work at Inatherys. Salaries, reviews, and more - all posted by employees working at Inatherys.See details»
INA-02 - Drug Targets, Indications, Patents - Synapse - Patsnap
INA-02: a CD89 inhibitors Drug, Initially developed by Inatherys SAS, Now, its global highest R&D status is Preclinical, Mechanism: CD89 inhibitors(IgA Fc receptor inhibitors), Therapeutic …See details»